The Trump administration has initiated sweeping layoffs at key US health agencies, with approximately 10,000 federal health workers receiving dismissal notices on Tuesday. Security guards turned away employees at building entrances after they received termination emails, creating chaotic scenes outside health department offices.
The cuts have targeted the Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health, raising concerns about the nation’s ability to respond to public health emergencies. Health Secretary Robert F. Kennedy Jr. described the reductions as necessary to streamline what he called a “bloated bureaucracy,” with plans to reduce total headcount from 82,000 to 60,000 employees.
Former FDA Commissioner Robert Califf warned in a LinkedIn post that the cuts have gutted institutional knowledge, stating “The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed.”
The layoffs have specifically affected key positions monitoring food safety and drug approvals. Among those terminated were FDA staff handling bird flu response, the agency’s tobacco control division, and critical scientists reviewing new medications. At the CDC, entire divisions were eliminated, including a team that recently ran drills for nuclear and radiological incidents.
Sponsored · Mercado Minerals Ltd.
The cuts are a part of the Trump administration’s broader push to cut government spending through the Elon Musk-led Department of Government Efficiency. Kennedy plans to consolidate the department’s 28 agency divisions into 15 new ones, including a new Administration for a Healthy America to implement his Make America Healthy Again agenda.
Critics, including former Speaker Nancy Pelosi, have condemned the cuts as dangerous to public health. Experts warn that Americans will likely experience slower approval of new medications, fewer food safety inspections, and potential lapses in new medical products as essential review staff have been terminated.
Despite HHS claims that the restructuring will save taxpayers $1.8 billion annually, Washington DC and 23 states have sued the federal government over related cuts to public health funding, which reduced COVID-era support by $11 billion last month.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
